Patrick Borgen, MD, on the Future of Personalized Medicine in Breast Cancer Care

When mentioning “breast cancer” in a story about my college experience is not allowed, I considered alternatives to the medical term that describes my situation best.

Darcie Green, executive director of service and advocacy organization Latinas Contra Cancer, tells the CURE® “Cancer Horizon” podcast about how its work has broadened over the last 20 years.

The PALLAS trial analyzed the impact of BMI in patients with early hormone receptor positive breast cancer.

A woman without a family history of breast cancer shares how she went from volunteering at breast cancer walks to one day finding herself in the shoes of someone living with the disease.

As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about side effect management in breast cancer care.

A woman with stage 4 inflammatory breast cancer details her journey with the disease and why it is important for patients to ask questions about anything going on with their bodies.